1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Morphine Abuse in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hagiwara, Y; Shoyama, Y; Sugiura, T; Tanaka, H; Waku, K; Watanabe, S; Yamaguchi, T; Yamamoto, T | 1 |
1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Morphine Abuse
Article | Year |
---|---|
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
Topics: Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Modulators; Cannabinoids; Central Nervous System; Dronabinol; Endocannabinoids; Glycerides; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Neurotransmitter Agents; Receptors, Cannabinoid; Receptors, Drug; Substance Withdrawal Syndrome | 2001 |